Skip to main content
Equibles
PNTG logo

PNTG · Pennant Group, Inc. · Metrics

Track PNTG — free

Use PNTG with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PNTG.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$36.07 +0.16 (+0.45%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$1.27B
Shares
35.13M
Volume · Nov 13 420.07K Avg daily vol (3M) 368.68K

PNTG metrics

104 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$36.07
Market cap
$1.27B

Price action

23 metrics
Price change (1W)
-0.8%
Price change (30D)
-14.7%
Price change (3M)
-8.3%
Price change (6M)
+1.5%
Price change (YTD)
+28.1%
Price change (1Y)
+44.9%
Trailing year
Price change (5Y)
+36.4%
52-week high
$44.04
52-week low
$24.89
Change from 52-week high
-18.1%
Change from 52-week low
+44.9%
Annualized volatility
39.5%
Annualized volatility (3M)
42.2%
Implied volatility (30D)
32.7%
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
0.4
RSI (14D)
37.0
Price vs SMA 50
-9.9%
Price vs SMA 200
+0.5%
Avg volume (3M)
368,684
Relative volume
1.1
Average dollar volume
$14.62M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
35.13M

Valuation

12 metrics
P / E (TTM)
36.1
Trailing earnings · reciprocal yield 2.8%
PEG ratio
0.7
EV / revenue
1.2×
reciprocal yield 81.5%
EV / EBITDA
18.0×
reciprocal yield 5.6%
EV / EBIT
21.1×
reciprocal yield 4.7%
P / sales
1.1×
reciprocal yield 92.7%
P / book
3.0
reciprocal yield 33.1%
FCF yield
2.7%
TTM · current market cap
Buyback yield
—
P / FCF
36.9
reciprocal yield 2.7%
P / operating cash flow
19.6
reciprocal yield 5.1%
Earnings yield
2.8%

Historical valuation

8 metrics
P / E historical average (3Y)
38.1×
reciprocal yield 2.6%
P / E historical average (5Y)
74.6×
reciprocal yield 1.3%
EV / revenue historical average (3Y)
1.3×
reciprocal yield 78.8%
EV / revenue historical average (5Y)
1.2×
reciprocal yield 84.0%
EV / EBIT historical average (3Y)
23.6×
reciprocal yield 4.2%
EV / EBIT historical average (5Y)
37.4×
reciprocal yield 2.7%
EV / EBITDA historical average (3Y)
20.1×
reciprocal yield 5.0%
EV / EBITDA historical average (5Y)
31.4×
reciprocal yield 3.2%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-11-05

Profitability

9 metrics
Gross margin
—
Operating margin
5.8%
Trailing 12 months
Net margin
3.1%
Gross profit (TTM)
—
Operating profit (TTM)
$68.47M
Net income (TTM)
$35.88M
Trailing 12 months
Diluted EPS (TTM)
$1.00
FCF margin
2.9%
Effective tax rate
25.7%

Per share

11 metrics
Revenue per diluted share (TTM)
$32.74
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$1.91
EBITDA per diluted share (TTM)
$2.24
Net income per diluted share (TTM)
$1.00
Operating cash flow per diluted share (TTM)
$1.79
Free cash flow per diluted share (TTM)
$0.96
Capital expenditures per diluted share (TTM)
$0.84
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.30
Book value per share
$10.81

Growth

11 metrics
Revenue growth YoY
+32.0%
Year over year
Net income growth YoY
+58.5%
Revenue (TTM)
$1.17B
Trailing 12 months
EPS growth YoY
+52.9%
Shares change YoY
+3.2%
Year over year · more shares
Revenue CAGR (3Y)
+26.0%
Revenue CAGR (5Y)
+19.4%
EPS CAGR (3Y)
+56.3%
EPS CAGR (5Y)
+10.1%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
-3.3%

Quality

14 metrics
Return on equity
8.5%
Return on assets
3.4%
Debt / equity
0.5
Current ratio
1.2
EBITDA (TTM)
$80.24M
Free cash flow (TTM)
$34.35M
Quick ratio
1.2
Interest coverage
5.2
Net debt / EBITDA
2.2
Return on invested capital
8.6%
Trailing 12 months
Net cash
−$174.94M
Latest balance sheet
Cash & equivalents
$18.39M
Total assets
$1.04B
Total debt
$193.33M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$64.50M
Capital expenditures (TTM)
$30.16M
R&D (TTM)
—
SG&A (TTM)
$81.28M
Stock compensation (TTM)
$10.95M
R&D / revenue
—
Stock compensation / revenue
0.9%

Ownership (13F)

9 metrics
13F filers
201
13F filer change QoQ
+12
Institutional ownership
90.1%
Conviction holders (share of 13F filers)
1.5%
Crowding (high-turnover and private-fund holders)
27.8%
Private-fund adviser ownership
26.0%
Active holders' share change QoQ
-0.4%
Holder tenure
14.9
Price vs estimated holder cost
+31.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
13.5%

Short interest

3 metrics
Short interest
3.3%
Latest settlement · 4.1 days to cover
Days to cover
4.1d
Short-squeeze score
63 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1766400 CUSIP 70805E109 13F (30d) 173 filings 158 filers Visit website Investor relations